Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMHSY1I)

Drug Name	Regorafenib DMHSY1I
Synonyms	Regorafenib; 755037-03-7; BAY 73-4506; Regorafenibum; Stivarga; 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide; BAY73-4506; Regorafenib (BAY 73-4506); UNII-24T2A1DOYB; 4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide; BAY-73-4506; 24T2A1DOYB; CHEMBL1946170; CHEBI:68647; Stivarga (TN); BAY73-4506 hydrochloride; Regorafenib [USAN:INN]
Drug Type	Small molecular drug
Structure
Structure	3D MOL			2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

3 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Metastasis from malignant tumor of colon	DIS175N9	N.A.	Approved	[1]
Gastrointestinal stromal tumour	DIS6TJYS	2B5B	Approved	[1]
Metastatic colorectal cancer	DIS18R3K	2B91	Approved	[2]
------------------------------------------------------------------------------------

References

1	Regorafenib FDA Label
2	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5891).